The study and its comparison
Twenty-six people entered a three-month open-label study of oral magnesium; 19 completed it. Participants recorded tinnitus distress, and investigators used handicap and severity questionnaires. [1]
Selected questionnaire scores improved after treatment. Everyone received magnesium, so there was no placebo comparison to separate the intervention from expectation, natural fluctuation or other changes. [1]
What the finding establishes
Incomplete follow-up and the small sample further limit confidence. The findings support controlled investigation rather than a universal tinnitus dose. They concern perceived handicap, not a direct demonstration that hearing damage was repaired. Funding and conflicts were not established from the retrieved abstract. Persistent symptoms still require an assessment of their cause. [1]
A hypothetical distinction
Imagine distress decreases while hearing thresholds are not measured. The result should retain the questionnaire’s meaning.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Phase 2 study examining magnesium-dependent tinnitus.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.